Singapore manufacturing output up 7.6% in November, better than estimates

Analysts had expected manufacturing to increase by 4.2% for last month.
Manufacturing factory in Singapore
Source: Bloomberg

Singapore’s manufacturing output gained 7.6% last month on a year-on-year basis, beating expectations due to output gains from the biomedical manufacturing and electronics clusters.

Analysts had expected manufacturing to increase by 4.2% for last month. Excluding the biomedical manufacturing cluster, manufacturing output rose by 5.3% on a year-on-year basis.

On a seasonally-adjusted month-on-month basis, manufacturing output increased 2.8% in November, supported by the biomedical cluster. On a cumulative period from January to November, total manufacturing gained by 7.9% on a year-on-year basis.

The electronics cluster, which contributes close to one-third of total manufacturing output, rose 11.2% on a year-on-year basis for last month, reversing from the two straight months of decline in October and September. The increase in November was supported mainly by output from the semiconductors and infocomms and consumer electronics segments.

The biomedical manufacturing cluster rose 18.5%, as pharmaceuticals and medical technology outputs rose by 23.9% and 6.6%, respectively.

The chemicals cluster gained by 3.4%, supported by the specialties and other items segments, which rose by 6.6% and 18.7%, respectively. The transport engineering cluster increased by 11.3%, as manufacturing output for marine and offshore engineering, aerospace, and land segments rose.

Meanwhile the precision engineering and general manufacturing clusters declined by 8.2% and 0.8%, respectively. The precision engineering cluster saw both its machinery and systems segment and precision modules and components segment contract in output, while the general manufacturing industries segment shrank due to a fall in printing output.

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IG Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.

Find articles by writer